Bausch Health
Laval
About Bausch Health
Bausch Health is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in four segments: Bausch+Lomb and international (55% of revenue), Salix pharmaceuticals (25%), ortho dermatology (6%), and diversified products (14%), and approximately 13% of revenue is attributable to non-U.S. markets. Bausch is the market leader in consumer visioncare in India and China, and the fourth- largest visioncare company by sales in the United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 10,001+
- Estimated revenue: $1M – $10M
- Total funding: $7.4B
- Funding stage: IPO
- Last round: Post-IPO Debt (May 2025)
- Ticker: nyse:BHC
- Website: bauschhealth.com
- Phone: (800) 361-1448
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bausch-health-83458 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.